Neuraceq
| Chemical Name | florbetaben F 18 |
| Dosage Form | Injection (intravenous; 50 to 5000 MBq/mL (1.4 to135 mCi/mL)) |
| Drug Class | Radioactive diagnostic agents |
| System | Nervous |
| Company | Life Molecular Imaging |
| Approval Year | 2014 |
Indication
- For positron emission tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive decline.